Valentini Alice, Dibnah Bethany, Ciba Marija, Duncan Elaine M, Manandhar Asmita, Strellis Bethany, Vita Luca, Lucianno Olivia, Massey Conor, Coe Sophie, Ulven Trond, Hudson Brian D, Rexen Ulven Elisabeth
Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark.
Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom.
Nat Commun. 2025 Jul 11;16(1):6413. doi: 10.1038/s41467-025-61690-5.
G protein coupled-receptors (GPCRs) are the largest family of signalling proteins and highly successful drug targets. Most GPCR targeting drugs interact with a binding pocket for the natural ligand of the receptor, typically near the extracellular region of the transmembrane domains. Advancements in structural biology have identified additional allosteric binding sites in other parts of these receptors. Allosteric sites provide theoretical advantages, including the ability to modulate natural ligand function, and there is a need for better ways to study how ligands interact with these different GPCR binding sites. Here we have developed an approach to study multiple ligands binding to the same GPCR at the same time based on sequential resonance energy transfer between two fluorescent ligands. We use this approach to define ligand pharmacology and to understand binding kinetics at the FFA1 free fatty acid receptor, a clinically relevant receptor. This approach to study GPCR ligand interactions will aid development of new GPCR drugs.
G蛋白偶联受体(GPCRs)是最大的信号蛋白家族,也是非常成功的药物靶点。大多数靶向GPCR的药物与受体天然配体的结合口袋相互作用,该口袋通常位于跨膜结构域的细胞外区域附近。结构生物学的进展已在这些受体的其他部位发现了额外的变构结合位点。变构位点具有理论优势,包括调节天然配体功能的能力,并且需要更好的方法来研究配体如何与这些不同的GPCR结合位点相互作用。在此,我们基于两个荧光配体之间的顺序共振能量转移,开发了一种同时研究多个配体与同一GPCR结合的方法。我们使用这种方法来定义配体药理学,并了解游离脂肪酸受体1(FFA1)(一种临床相关受体)的结合动力学。这种研究GPCR配体相互作用的方法将有助于新型GPCR药物的开发。